Psychiatry Research 117 (2003) 127135. Premature mortality in schizophrenia: a 7.5-year study. Maria G. Morgan , Paul J. Scully , Hanafy A. Youssef , a,b a,b a Anthony Kinsellac, John M. Owensa, John L. Waddingtona,b,* http://psychrights.org/Research/Digest/NLPs/MM-PsychRes2003.pdf (100 KB pdf via psychrights.org) Abstract While premature death in schizophrenia is well recognised,…
Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ Fri, 29 Jul 2005 The Wall Street Journal uncritically reported: “The results of the largest studies ever conducted of depression and schizophrenia will be released in coming months, potentially transforming the way patients are treated and shaking…
Phrma found new market for psychotropic drugs: Toledo Zoo Wed, 14 Sep 2005 The Toledo Blade reports: “Now that humans have warmly embraced citizenship in the Prozac Nation, zoo animals are making tentative gallops, flights, and knuckle-walks into the world of psychotropic pharmaceuticals.” However, these drugs have nasty side effects…
Psychiatry’s Claims Re: Brain Imaging Have Far Outpaced Science – NYT Tue, 18 Oct 2005 A front page report in The New York Times Science section pulls the rug out from yet another of psychiatry’s myths. Benedict Carey reports: “Not long ago, scientists predicted that these images, produced by sophisticated…
APA Under the Influence of PhaRma June 5, 2002 FYI Reporters who attended the 2002 annual convention of the American Association of Psychiatry / PhaRma have had a rude awakening about the scope of industry’s influence. Essentially, psychiatrists are drug marketers for industry, helping to create blockbuster sales: Even…
Ethics of U Penn surgical “drug implant” experiment Tuesday, October 07 Notwithstanding a legion of prominent bioethicists at major universities such as the University of Pennsylvania and Johns Hopkins University, researchers at these institutions are not deterred from engaging in high risk human experimentation whose ethics are questionable. One has…
TeenScreen: Who Pays for Treatment and Drugs?? Sun, 29 May 2005 In her latest examination of the President’s Commission on Mental Health recommendation for universal mental health screening, Evelyn Pringle focuses on the $$$ it costs and on how screening, followed by prescribing psychotropic drugs, is bankrupting of public health…
NYT Editorial: comparing schizophrenia drugs Wed, 21 Sep 2005 Today’s New York Times Editorial acknowledges: “A government-financed study has provided the strongest evidence yet that the system for approving and promoting drugs is badly out of whack. The study compared five drugs used to treat schizophrenia and found that most…
Epidemiologist Says Most Published Research Findings Are False – Psychiatrist Addresses Credibility Crisis Sat, 8 Oct 2005 An article published in PLoS Medical (an Open Access Peer Reviewed Medical Journal) by an epidemiologist who holds academic positions on both sides of the Atlantic–at the University of Ioannina (Greece) and Tufts…
Screening for Mental Illness–A Diabolical, Profit-Enhancing Experiment Fri, 22 Oct 2004 Concerned citizen groups are joining our effort to stop the government from implementing a sweeping recommendation for lifetime screening for mental illness. If implemented, the first to be screened for hidden mental illness are America’s 52 million school children…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children: "minimal risk" "minor increment of minimal risk" and "disorder or condition" January 28, 2001 A cornerstone of the Declaration of Helsinki (adopted by the World Medical Association in 1964, and reaffirmed on Oct. 2000) is the distinction between research…
